论文部分内容阅读
回顾性分析428例行改良根治术乳腺癌(Ⅰ期167例,Ⅱ期261例)患者及随机抽取同期行Halsted根治术的乳腺癌患者180例(Ⅰ期66例,Ⅱ期114例)的临床资料。探讨乳腺癌改良根治术的临床疗效。结果:乳腺癌Ⅰ、Ⅱ期患者改良根治术5年生存率与根治术无统计学差异(P均>0.05)。提示乳腺癌Ⅰ、Ⅱ期患者行改良根治术优于根治术。
A retrospective analysis of 428 cases of modified radical mastectomy (167 cases of stage Ⅰ, 261 cases of stage Ⅱ) and 180 cases of Halsted radical mastectomy in patients with breast cancer (66 cases in stage Ⅰ and 114 in stage Ⅱ) data. To investigate the clinical effect of modified radical mastectomy for breast cancer. Results: There was no significant difference in the 5-year survival rate between radical mastectomy and radical mastectomy in patients with stage Ⅰ and Ⅱ breast cancer (all P> 0.05). Prompted breast cancer Ⅰ, Ⅱ patients with modified radical mastectomy is better than radical mastectomy.